Binding and uptake of immunostimulatory CpG oligodeoxynucleotides by human neuroblastoma cells

Liang-Hao Guo1, Hermann J Schluesener

  • 1Institute of Brain Research, University of Tuebingen, D-72076, Tuebingen, Germany.

Oligonucleotides
|January 25, 2005
PubMed

Insights

Oligodeoxynucleotides (CpG-ODN) are taken up by neuroblastoma cells via a non-specific mechanism. This uptake is independent of the CpG motif, suggesting broad therapeutic potential for oligonucleotide drugs.

Area of Science:

  • Immunology
  • Molecular Biology
  • Oncology

Background:

  • Oligodeoxynucleotides (ODNs) with unmethylated CpG motifs (CpG-ODN) stimulate innate immunity.
  • CpG-ODN have shown efficacy in experimental neuroblastoma eradication.
  • Direct interaction of CpG-ODN with neuroblastoma cells remains uninvestigated.

Purpose of the Study:

  • To investigate the uptake, binding, and intracellular distribution of CpG-ODN in SK-NSH neuroblastoma cells.
  • To determine the role of the CpG motif in these cellular interactions.
  • To elucidate mechanisms relevant to oligonucleotide biodistribution and drug design in tumors.

Main Methods:

  • Cellular uptake assays of CpG-ODN in SK-NSH cells.
  • Analysis of CpG-ODN binding and intracellular localization.
  • Investigation of dose, time, temperature, and energy dependence of uptake.
  • Assessment of CpG motif independence.

Main Results:

  • CpG-ODN cellular uptake is dependent on dose, time, temperature, and energy.
  • Uptake is independent of the CpG motif.
  • Internalized CpG-ODN localize to the cytoplasm in a speckled pattern.
  • Intracellular distribution and binding proteins are CpG motif independent.

Conclusions:

  • Neuroblastoma cells internalize CpG-ODN via a non-specific oligonucleotide transfer mechanism.
  • CpG-ODN interact with intracellular proteins independent of the CpG motif.
  • Understanding these mechanisms can inform oligonucleotide biodistribution and therapeutic drug design for neuroblastoma.

Related Concept Videos